Biotech’s three biggest innovators

Each week, a professional investor tells MoneyWeek where he’d put his money now. This week: Dr Daniel Koller, head of BB Biotech, Bellevue Asset Management.

The biotechnology sector has reached a certain level of maturity. In the early years, the only companies that investors had to choose from were highly speculative punts in small unproven start-ups. These days there is a wide range of profitable and well-run biotech companies to invest in.

Most of them are headquartered in the US and listed on the tech-focused Nasdaq stock exchange.

These companies have made great progress in clinical research and development over [...]

MoneyWeek magazine

Latest issue:

Magazine cover
Don't be spooked by Putin

Take a punt on eastern Europe

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues
Shale gas 'fracking' promises to transform Britain's energy market. Find out what it is, what it means, and how to invest.

More from MoneyWeek

What you should really do with your money (2014 Edition)

How to buy and sell penny shares

A beginner's guide to investing in gold

How to invest in British fracking

Which investment platform?

When it comes to buying shares and funds, there are several investment platforms and brokers to choose from. They all offer various fee structures to suit individual investing habits.
Find out which one is best for you.